MPs take evidence on variant Creutzfeldt-Jakob Disease (vCJD)

27 November 2013

The Science and Technology Committee has decided to hold an oral evidence session on variant Creutzfeldt-Jakob Disease (vCJD) and the ongoing risk it poses to the UK.


Wednesday 27 November 2013, Thatcher Room, Portcullis House

At 9.05 am

  • Dr Roland Salmon, Joint Chair, Advisory Committee on Dangerous Pathogens TSE Sub Group
  • Professor James Ironside, Professor of Clinical Neuropathology, National CJD Research and Surveillance Unit, University of Edinburgh
  • Professor John Collinge, Professor of Neurology at the UCL Institute of Neurology and Director of the MRC Prion Unit

The Committee will hear evidence from scientific experts on the potential prevalence of vCJD in the population, modes of ongoing transmission and current UK surveillance, control and prevention strategies.

Andrew Miller MP, Chair of the Science and Technology Committee, said:

“More than twenty years on from the BSE crisis, studies have suggested that thousands of people may still carry the infectious agent thought to cause variant Creutzfeldt-Jakob Disease—the human form of “mad cow disease”.

“Although these people may never go on to develop symptoms of vCJD, important questions remain to be asked about the potential risk posed by this terrible condition and what the Government should be doing to reduce the spread of infection.”

Further information

Image: Parliamentary copyright

More news on: Health services and medicine, Parliament, government and politics, Parliament, Health education and preventive medicine, Communicable diseases, Diseases, House of Commons news, Commons news, Committee news

Share this page